tirzepatide appetite suppression side effects How Suppresses Appetite: Clinical Mechanisms tirzepatide appetite suppression side effects

The SURMOUNT-1 trial showed 22.5% average weight loss with tirzepatide at 15 mg, compared to 14.9% with semaglutide at 2.4 mg in the STEP-1 trial

Like Alices discoveries in Wonderland, we found disproportionate reporting signals for several medications, including methylphenidate in youths, and montelukast, aripiprazole, sertraline, and topiramate in adults

And the published study, while valuable, was retrospective, company-authored, and lacks a control group - limitations that any informed consumer should weigh alongside the results

Doerge DR, Sheehan DM

However, if your goal is losing fat while retaining lean muscle, a compound like AOD-9604, Sermorelin, or Ipamorelin might be more appropriate